These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
43. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331 [TBL] [Abstract][Full Text] [Related]
45. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Rowe M; Lear AL; Croom-Carter D; Davies AH; Rickinson AB J Virol; 1992 Jan; 66(1):122-31. PubMed ID: 1309242 [TBL] [Abstract][Full Text] [Related]
46. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663 [TBL] [Abstract][Full Text] [Related]
47. Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. Yokoyama A; Tanaka M; Matsuda G; Kato K; Kanamori M; Kawasaki H; Hirano H; Kitabayashi I; Ohki M; Hirai K; Kawaguchi Y J Virol; 2001 Jun; 75(11):5119-28. PubMed ID: 11333893 [TBL] [Abstract][Full Text] [Related]
48. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. Jiang H; Cho YG; Wang F J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073 [TBL] [Abstract][Full Text] [Related]
49. Early events in Epstein-Barr virus infection of human B lymphocytes. Alfieri C; Birkenbach M; Kieff E Virology; 1991 Apr; 181(2):595-608. PubMed ID: 1849678 [TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. Lin J; Johannsen E; Robertson E; Kieff E J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688 [TBL] [Abstract][Full Text] [Related]
51. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610 [TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607 [TBL] [Abstract][Full Text] [Related]
53. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472 [TBL] [Abstract][Full Text] [Related]
54. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. Zhang L; Pagano JS J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515 [TBL] [Abstract][Full Text] [Related]
55. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene. Harada S; Yanagi K Microbiol Immunol; 1992; 36(5):479-94. PubMed ID: 1325025 [TBL] [Abstract][Full Text] [Related]
56. Immortalizing genes of Epstein-Barr virus. Middleton T; Gahn TA; Martin JM; Sugden B Adv Virus Res; 1991; 40():19-55. PubMed ID: 1659776 [TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875 [TBL] [Abstract][Full Text] [Related]
58. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]
59. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. Rooney CM; Brimmell M; Buschle M; Allan G; Farrell PJ; Kolman JL J Virol; 1992 Jan; 66(1):496-504. PubMed ID: 1309259 [TBL] [Abstract][Full Text] [Related]